FAM
ONC

Fred Alger Management’s BeOne Medicines Ltd ONC Stock Holding History

Fred Alger Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,843
Closed -$1.31M – 518
2025
Q3 		$1.31M Buy
+3,843
New +$1.17M 0.01% 344
2025
Q2 		– Sell
-3,307
Closed -$900K – 484
2025
Q1 		$900K Buy
+3,307
New +$773K 0.01% 334
2021
Q3 		– Sell
-4,057
Closed -$1.39M – 572
2021
Q2 		$1.39M Sell
4,057
-174
-4% -$57.6K ﹤0.01% 373
2021
Q1 		$1.47M Sell
4,231
-62
-1% -$20.5K ﹤0.01% 361
2020
Q4 		$1.11M Sell
4,293
-97
-2% -$26.7K ﹤0.01% 364
2020
Q3 		$1.26M Buy
4,390
+1,390
+46% +$327K ﹤0.01% 327
2020
Q2 		$565K Buy
+3,000
New +$488K ﹤0.01% 392
2019
Q2 		– Sell
-6,000
Closed -$792K – 568
2019
Q1 		$792K Buy
+6,000
New +$810K ﹤0.01% 351
2018
Q4 		– Sell
-20,799
Closed -$3.58M – 580
2018
Q3 		$3.58M Buy
20,799
+2,811
+16% +$473K 0.01% 251
2018
Q2 		$2.77M Buy
17,988
+2,718
+18% +$485K 0.01% 264
2018
Q1 		$2.56M Buy
+15,270
New +$2.07M 0.01% 277

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Fred Alger Management's ONC Position: Q4 2025 in Review

Fred Alger Management sold out of BeOne Medicines Ltd (ONC) in Q4 2025, closing a stake of 3,843 shares — an estimated $1.31M sold.

Fred Alger Management first reported a position in ONC in Q1 2018 and held it in 11 quarters. The position peaked at $3.58M in Q3 2018. 285 funds tracked by Wall St. Rank hold ONC as of Q4 2025.

  • Fred Alger Management reported no remaining BeOne Medicines Ltd position as of Q4 2025 after selling out during the quarter.
  • Fred Alger Management sold 3,843 BeOne Medicines Ltd shares in Q4 2025, an estimated $1.31M.
  • Fred Alger Management first reported a position in BeOne Medicines Ltd in Q1 2018 and held it in 11 quarters.
  • Fred Alger Management's BeOne Medicines Ltd position peaked at $3.58M in Q3 2018.
  • 285 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2025.

Based on Fred Alger Management's 13F filing for Q4 2025, filed 17 Feb 2026.